State-of-the-art patient self-management for control of oral anticoagulation

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 1, 1999, Pages 43-48

  Taborski, Uwe ^a   Müller Berghaus, Gert ^a  

^a KERCKHOFF HEART CENTER   (Germany)

Author keywords

Home monitors; Oral anticoagulation therapy; Patient self management; Prothrombin times

Indexed keywords

ANTICOAGULANT AGENT;

ACCURACY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; DEVICE; DRUG MONITORING; DRUG SAFETY; GERMANY; HEALTH INSURANCE; HEALTH PROGRAM; HOME MONITORING; HUMAN; ORAL DRUG ADMINISTRATION; PATIENT EDUCATION; PRIORITY JOURNAL; PROTHROMBIN TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032938443     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996423     Document Type: Article

References (18)

1. 1. Produktgruppe 21 "Meßgeräte für Körperzustände/-funktionen," Hilfsmittelverzeichnis nach §128 SGB V. Bundesanzeiger Ausgabe 79 vom 25.04.1996
2. 2. Arbeitsgemeinschaft Selbstkontrolle der Antikoagulation: Standards und Informationen. Bernardo A, Taborski U, Wittstamm FJ, eds. Bad Nauheim: Eigenverlag; 4. Aufl. 1996
3. 3. Sawicki PT. A structured teaching and self-management program for patients recieving oral anticoagulation. JAMA 1999;281:145-150.
4. 4. van den Besselaar AMHP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coag Fibrinolysis 1995;6:726-732
5. 5. Taborski U, Schüpphaus S, Böker C, et al. Vergleich PT-So-fortbestimmung mit konventioneller Labormethode an drei Zentren. Ann Hematol 1992;64(Abst):A18
6. 6. Kapiotis S, Quehenberger P, Speiser W. Prothrombin time determination. Thromb Res 1995;77:563-567
7. 7. Hasenkam JM, Knudsen L, Kimose HH, et al. Practicability of patient self-testing of oral anticoagulant therapy by the international normalized ratio (INR) using a portable whole blood monitor. Thromb Res 1997;85:77-82
8. 8. Kaatz SS, White RH, Hill J, et al. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 1995:155:1861-1867
9. 9. Horstkotte D, Piper C, Wiemer M, Schulte HD, Schultheiß HP. Optimization of oral anticoagulation following valve replacement: Results of prospective randomized studies. Ann Hematol 1996;72(Suppl. I) (Abst):A90
10. 10. Taborski U, Heidinger K, Müller-Berghaus G. Imprecision of INR self-testing compared to laboratory testing. Ann Hematol 1998;76(Suppl. I)(Abst):A100
11. 11. Bernardo A. Quickwert-Selbstbestimmung durch den Patienten nach Herzklappenersatz. Präv Rehab 1992;4:84-88
12. 12. Bernardo A, Schüpphaus S, Taborski U, Wittstamm FJ. Die Selbstkontrolle der oralen Antikoagulation. Dtsch Ärzteblatt 1995;92:A442-444
13. 13. Bernardo A, Halhuber C, Horstkotte D. Home prothrombin estimation. In: Butchart EG, Bodnar E, eds. Thrombosis, Embolism and Bleeding. London, ICR Publishers; 1992:325-330
14. 14. Bernardo A. Post-Conference Session: Experience with patient self-management of oral anticoagulation. J Thromb Thrombolysis 1996;2:321-325
15. 15. Ansell J, Patel N, Ostrovsky D, et al. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995; 155:2185-2189
16. 16. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998;5:19-24
17. 17. Hasenkam JM, Kimose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997;11:935-942
18. 18. Körfer R, Körtke H. ESCAT: Early Self-Controlled Anticoagulation Trial. In: Krian A, Matloff JM, Nicoloff DM (eds). Advancing the Technology of Bileaflet Mechanical Heart Valves. Darmstadt, Germany: Steinkopft-Verlag; 1998:12-22